Avoid common mistakes on your manuscript.
Retraction Note: Naunyn–Schmiedeberg's Archives of Pharmacology (2019) 392:1331–1345
The Editor-in-Chief has retracted this article. After publication, concerns were raised regarding the electron microscopy images presented in Fig. 2. Specifically:
-
Fig. 2c appears to overlap with Fig. 2f with a few different features;
-
Fig. 2h appears to contain duplicated patterns.
The authors have provided the original image files to address these concerns. However, the Publisher's analysis of these files found duplicated patterns present in the majority of the images. The Editor-in-Chief therefore no longer has confidence in the presented data.
Sara A. Wahdan and Ebtehal El-Demerdash do not agree to this retraction. Samar S. Azab and Doaa A. Elsherbiny have not responded to any correspondence from the publisher about this retraction.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wahdan, S.A., Azab, S.S., Elsherbiny, D.A. et al. Retraction Note: Piceatannol protects against cisplatin nephrotoxicity via activation of Nrf2/HO-1 pathway and hindering NF-κB inflammatory cascade. Naunyn-Schmiedeberg's Arch Pharmacol 396, 3897 (2023). https://doi.org/10.1007/s00210-023-02780-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-023-02780-3